Literature DB >> 1699952

Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.

W H Burgess1, A M Shaheen, M Ravera, M Jaye, P J Donohue, J A Winkles.   

Abstract

The fibroblast or heparin-binding growth factors (HBGFs) are thought to be modulators of cell growth and migration, angiogenesis, wound repair, neurite extension, and mesoderm induction. A better understanding of the structural basis for the different activities of these proteins should facilitate the development of agonists and antagonists of specific HBGF activities and identification of the signal transduction pathways involved in the mechanisms of action of these growth factors. Chemical modification studies of Harper and Lobb (Harper, J. W., and R. R. Lobb. 1988. Biochemistry. 27:671-678) implicated lysine 132 in HBGF-1 (acidic fibroblast growth factor) as being important to the heparin-binding, receptor-binding, and mitogenic activities of the protein. We changed lysine 132 to a glutamic acid residue by site-directed mutagenesis of the human cDNA and expressed the mutant protein in Escherichia coli to obtain sufficient quantities for functional studies. Replacement of this lysine with glutamic acid reduces the apparent affinity of HBGF-1 for immobilized heparin (elutes at 0.45 M NaCl vs. 1.1 M NaCl for wild-type). Mitogenic assays established two points: (a) human recombinant HBGF-1 is highly dependent on the presence of heparin for optimal mitogenic activity, and (b) the change of lysine 132 to glutamic acid drastically reduces the specific mitogenic activity of HBGF-1. The poor mitogenic activity of the mutant protein does not appear to be due to a reduced affinity for the HBGF receptor. Similarly, the mutant HBGF-1 can stimulate tyrosine kinase activity and induce protooncogene expression. Differences in the biological properties of the wild-type and mutant proteins were observed in transfection studies. Mutant HBGF-1 expression in transfected NIH 3T3 cells did not induce the same transformed phenotype characteristic of cells expressing wild-type HBGF-1. Together these data indicate that different functional properties of HBGF-1 may be dissociated at the structural level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699952      PMCID: PMC2116333          DOI: 10.1083/jcb.111.5.2129

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

1.  Detection and characterization of heparin-binding proteins with a gel overlay procedure.

Authors:  T Mehlman; W H Burgess
Journal:  Anal Biochem       Date:  1990-07       Impact factor: 3.365

2.  A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.

Authors:  J A Escobedo; L T Williams
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

3.  Nuclear and cytoplasmic localization of different basic fibroblast growth factor species.

Authors:  M Renko; N Quarto; T Morimoto; D B Rifkin
Journal:  J Cell Physiol       Date:  1990-07       Impact factor: 6.384

4.  Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor.

Authors:  W H Burgess; T Mehlman; D R Marshak; B A Fraser; T Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Receptor- and heparin-binding domains of basic fibroblast growth factor.

Authors:  A Baird; D Schubert; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression.

Authors:  C G Gay; J A Winkles
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

7.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

8.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

9.  EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

Authors:  B Margolis; S G Rhee; S Felder; M Mervic; R Lyall; A Levitzki; A Ullrich; A Zilberstein; J Schlessinger
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

10.  Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2.

Authors:  C Dickson; R Smith; S Brookes; G Peters
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

View more
  26 in total

Review 1.  Growth regulatory factors and bone.

Authors:  G R Mundy; D Chen; M Zhao; S Dallas; C Xu; S Harris
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Jae Myoung Suh; Annette R Atkins; Michael Downes; Ronald M Evans; Connie A Tenorio; Ewa Bienkiewicz; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-10-20       Impact factor: 3.534

3.  Organization, chromosomal localization and promoter analysis of the gene encoding human acidic fibroblast growth factor intracellular binding protein.

Authors:  E Kolpakova; E Frengen; T Stokke; S Olsnes
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA.

Authors:  R A Payson; H Canatan; M A Chotani; W P Wang; S E Harris; R L Myers; I M Chiu
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

5.  A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.

Authors:  A Isacchi; M Statuto; R Chiesa; L Bergonzoni; M Rusnati; P Sarmientos; G Ragnotti; M Presta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library.

Authors:  A Yayon; D Aviezer; M Safran; J L Gross; Y Heldman; S Cabilly; D Givol; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Binding of FGF-1 variants to protein kinase CK2 correlates with mitogenicity.

Authors:  Camilla Skiple Skjerpen; Trine Nilsen; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

9.  Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.

Authors:  A E Eriksson; L S Cousens; B W Matthews
Journal:  Protein Sci       Date:  1993-08       Impact factor: 6.725

10.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.